162 related articles for article (PubMed ID: 30538490)
1. Alcoholic liver disease and risk of cholangiocarcinoma: a systematic review and meta-analysis.
Xiong J; Yin Z; Xu W; Shen Z; Li Y; Lu X
Onco Targets Ther; 2018; 11():8211-8219. PubMed ID: 30538490
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies.
Li H; Hu B; Zhou ZQ; Guan J; Zhang ZY; Zhou GW
World J Surg Oncol; 2015 Apr; 13():161. PubMed ID: 25903488
[TBL] [Abstract][Full Text] [Related]
3. Aspirin use is associated with a reduced risk of cholangiocarcinoma: a systematic review and meta-analysis.
Xiong J; Xu W; Bian J; Huang H; Bai Y; Xu Y; Lu X; Zhao H
Cancer Manag Res; 2018; 10():4095-4104. PubMed ID: 30323665
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis.
Wongjarupong N; Assavapongpaiboon B; Susantitaphong P; Cheungpasitporn W; Treeprasertsuk S; Rerknimitr R; Chaiteerakij R
BMC Gastroenterol; 2017 Dec; 17(1):149. PubMed ID: 29216833
[TBL] [Abstract][Full Text] [Related]
5. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.
Tan JH; Zhou WY; Zhou L; Cao RC; Zhang GW
Turk J Gastroenterol; 2020 Mar; 31(3):246-256. PubMed ID: 32343237
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma.
Xiong J; Wang Y; Huang H; Bian J; Wang A; Long J; Zheng Y; Sang X; Xu Y; Lu X; Zhao H
Oncotarget; 2017 Aug; 8(35):59648-59657. PubMed ID: 28938668
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and the risk of cholangiocarcinoma: a hospital-based case-control study in China.
Xiong J; Lu X; Xu W; Bai Y; Huang H; Bian J; Zhang L; Long J; Xu Y; Wang Z; Zhao H
Cancer Manag Res; 2018; 10():3849-3855. PubMed ID: 30288116
[TBL] [Abstract][Full Text] [Related]
9. Smoking and risk of cholangiocarcinoma: a systematic review and meta-analysis.
Huang Y; You L; Xie W; Ning L; Lang J
Oncotarget; 2017 Nov; 8(59):100570-100581. PubMed ID: 29246002
[TBL] [Abstract][Full Text] [Related]
10. Differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound: A systematic review and meta-analysis.
Chen Y; Zhu Y; Chen K; Wang H; Zhang W; Bao J; Wang W
Clin Hemorheol Microcirc; 2021; 79(2):293-309. PubMed ID: 33935070
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
[TBL] [Abstract][Full Text] [Related]
12. Cholelithiasis and the risk of intrahepatic cholangiocarcinoma: a meta-analysis of observational studies.
Cai H; Kong WT; Chen CB; Shi GM; Huang C; Shen YH; Sun HC
BMC Cancer; 2015 Nov; 15():831. PubMed ID: 26526500
[TBL] [Abstract][Full Text] [Related]
13. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.
Bertuccio P; Malvezzi M; Carioli G; Hashim D; Boffetta P; El-Serag HB; La Vecchia C; Negri E
J Hepatol; 2019 Jul; 71(1):104-114. PubMed ID: 30910538
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis.
Jing W; Jin G; Zhou X; Zhou Y; Zhang Y; Shao C; Liu R; Hu X
Eur J Cancer Prev; 2012 Jan; 21(1):24-31. PubMed ID: 21857525
[TBL] [Abstract][Full Text] [Related]
15. Does high-grade dysplasia/carcinoma in situ of the biliary duct margin affect the prognosis of extrahepatic cholangiocarcinoma? A meta-analysis.
Ke Q; Wang B; Lin N; Wang L; Liu J
World J Surg Oncol; 2019 Dec; 17(1):211. PubMed ID: 31818290
[TBL] [Abstract][Full Text] [Related]
16. Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: a meta-analysis.
Ye XH; Huai JP; Ding J; Chen YP; Sun XC
World J Gastroenterol; 2013 Dec; 19(46):8780-8. PubMed ID: 24379600
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors and odds of cholangiocarcinoma: A retrospective case-control study.
Xiong J; Wang Y; Xu W; Liu Z; Wang H; Zhang Z; Han Y; Yin C; Cao S; Yang Z; Su T; Wei J; Chen G; Jin L
Liver Int; 2020 Nov; 40(11):2848-2857. PubMed ID: 32910500
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
Tang Z; Yang Y; Wang X; Meng W; Li X
BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis.
Trikudanathan G; Navaneethan U; Njei B; Vargo JJ; Parsi MA
Gastrointest Endosc; 2014 May; 79(5):783-9. PubMed ID: 24140129
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic ultrasound in the diagnosis of cholangiocarcinoma as the etiology of biliary strictures: a systematic review and meta-analysis.
Navaneethan U; Njei B; Venkatesh PG; Lourdusamy V; Sanaka MR
Gastroenterol Rep (Oxf); 2015 Aug; 3(3):209-15. PubMed ID: 25169922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
